Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4895
pubmed:dateCreated
1989-4-7
pubmed:databankReference
pubmed:abstractText
Focal adhesion of leukocytes to the blood vessel lining is a key step in inflammation and certain vascular disease processes. Endothelial leukocyte adhesion molecule-1 (ELAM-1), a cell surface glycoprotein expressed by cytokine-activated endothelium, mediates the adhesion of blood neutrophils. A full-length complementary DNA (cDNA) for ELAM-1 has now been isolated by transient expression in COS cells. Cells transfected with the ELAM-1 clone express a surface structure recognized by two ELAM-1 specific monoclonal antibodies (H4/18 and H18/7) and support the adhesion of isolated human neutrophils and the promyelocytic cell line HL-60. Expression of ELAM-1 transcripts in cultured human endothelial cells is induced by cytokines, reaching a maximum at 2 to 4 hours and decaying by 24 hours; cell surface expression of ELAM-1 protein parallels that of the mRNA. The primary sequence of ELAM-1 predicts an amino-terminal lectin-like domain, an EGF domain, and six tandem repetitive motifs (about 60 amino acids each) related to those found in complement regulatory proteins. A similar domain structure is also found in the MEL-14 lymphocyte cell surface homing receptor, and in granule-membrane protein 140, a membrane glycoprotein of platelet and endothelial secretory granules that can be rapidly mobilized (less than 5 minutes) to the cell surface by thrombin and other stimuli. Thus, ELAM-1 may be a member of a nascent gene family of cell surface molecules involved in the regulation of inflammatory and immunological events at the interface of vessel wall and blood.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0036-8075
pubmed:author
pubmed:issnType
Print
pubmed:day
3
pubmed:volume
243
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1160-5
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:2466335-Amino Acid Sequence, pubmed-meshheading:2466335-Base Sequence, pubmed-meshheading:2466335-Cell Adhesion, pubmed-meshheading:2466335-DNA, pubmed-meshheading:2466335-E-Selectin, pubmed-meshheading:2466335-Endothelium, Vascular, pubmed-meshheading:2466335-Gene Expression Regulation, pubmed-meshheading:2466335-Humans, pubmed-meshheading:2466335-Immunoassay, pubmed-meshheading:2466335-Interleukin-1, pubmed-meshheading:2466335-Membrane Glycoproteins, pubmed-meshheading:2466335-Molecular Sequence Data, pubmed-meshheading:2466335-Neutrophils, pubmed-meshheading:2466335-Nucleic Acid Hybridization, pubmed-meshheading:2466335-Recombinant Proteins, pubmed-meshheading:2466335-Sequence Homology, Nucleic Acid, pubmed-meshheading:2466335-Transcription, Genetic, pubmed-meshheading:2466335-Transfection, pubmed-meshheading:2466335-Tumor Cells, Cultured, pubmed-meshheading:2466335-Tumor Necrosis Factor-alpha
pubmed:year
1989
pubmed:articleTitle
Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins.
pubmed:affiliation
Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't